Clinical Trials Browser

Phase 2 × Breast Diseases × dalpiciclib × Clear all

NCT07581834 2026-05-12

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Phase 2 Recruiting

Breast Diseases, Breast Neoplasms